Bonnin, R.A.; Bernabeu, S.; Emeraud, C.; Naas, T.; Girlich, D.; Jousset, A.B.; Dortet, L.
In Vitro Activity of Imipenem-Relebactam, Meropenem-Vaborbactam, Ceftazidime-Avibactam and Comparators on Carbapenem-Resistant Non-Carbapenemase-Producing Enterobacterales. Antibiotics 2023, 12, 102.
https://doi.org/10.3390/antibiotics12010102
AMA Style
Bonnin RA, Bernabeu S, Emeraud C, Naas T, Girlich D, Jousset AB, Dortet L.
In Vitro Activity of Imipenem-Relebactam, Meropenem-Vaborbactam, Ceftazidime-Avibactam and Comparators on Carbapenem-Resistant Non-Carbapenemase-Producing Enterobacterales. Antibiotics. 2023; 12(1):102.
https://doi.org/10.3390/antibiotics12010102
Chicago/Turabian Style
Bonnin, Rémy A., Sandrine Bernabeu, Cécile Emeraud, Thierry Naas, Delphine Girlich, Agnès B. Jousset, and Laurent Dortet.
2023. "In Vitro Activity of Imipenem-Relebactam, Meropenem-Vaborbactam, Ceftazidime-Avibactam and Comparators on Carbapenem-Resistant Non-Carbapenemase-Producing Enterobacterales" Antibiotics 12, no. 1: 102.
https://doi.org/10.3390/antibiotics12010102
APA Style
Bonnin, R. A., Bernabeu, S., Emeraud, C., Naas, T., Girlich, D., Jousset, A. B., & Dortet, L.
(2023). In Vitro Activity of Imipenem-Relebactam, Meropenem-Vaborbactam, Ceftazidime-Avibactam and Comparators on Carbapenem-Resistant Non-Carbapenemase-Producing Enterobacterales. Antibiotics, 12(1), 102.
https://doi.org/10.3390/antibiotics12010102
